4//SEC Filing
Alles Mark J 4
Accession 0001209191-23-049977
CIK 0001556263other
Filed
Sep 18, 8:00 PM ET
Accepted
Sep 19, 4:47 PM ET
Size
7.6 KB
Accession
0001209191-23-049977
Insider Transaction Report
Form 4
Alles Mark J
Director
Transactions
- Exercise/Conversion
Common Stock
2023-09-16+2,666→ 3,666 total - Exercise/Conversion
Restricted Stock Units
2023-09-16−2,666→ 5,334 total→ Common Stock (2,666 underlying)
Footnotes (4)
- [F1]Represents shares of common stock received upon vesting of a restricted stock unit award.
- [F2]On September 16, 2022, the issuer effected a 1-for-10 reverse stock split of its common stock (the "Reverse Stock Split"). The amount of securities reported on this Form 4 have been adjusted to reflect the Reverse Stock Split.
- [F3]Each restricted stock unit ("RSU") represents the contingent right to receive one share of the issuer's common stock.
- [F4]Represents a restricted stock unit award granted on September 16, 2022. These restricted stock units vest in three equal annual installments commencing on September 16, 2023.
Documents
Issuer
Syros Pharmaceuticals, Inc.
CIK 0001556263
Entity typeother
Related Parties
1- filerCIK 0001538897
Filing Metadata
- Form type
- 4
- Filed
- Sep 18, 8:00 PM ET
- Accepted
- Sep 19, 4:47 PM ET
- Size
- 7.6 KB